Leading Bioanalytical Testing CROs
.png)
Published: January 2026
Bioanalytical testing measures drugs, their breakdown products, or biomarkers in body fluids like blood, urine, or tissue. It uses techniques such as mass spectrometry or immunoassays to get precise quantities. This helps track how medicines move through the body during drug development and clinical trials, ensuring safety and effectiveness.
A contract research organization is a company that supports pharmaceutical, biotech and medical device firms by running research and clinical trials for them. These organizations provide specialized services such as study design, site management, data analysis and regulatory support so sponsors can save time, reduce costs and access expert teams without building everything in house.
Bioanalytical testing plays a crucial role in the services offered by contract research organizations, since it helps generate reliable data on drug safety, efficacy and pharmacokinetics throughout development. CROs integrate advanced bioanalytical methods to support preclinical and clinical studies, ensuring that drug concentrations, biomarkers and impurities are measured accurately and consistently. By combining specialized laboratories, trained scientists and regulatory compliant workflows, CROs help sponsors quicken decision making, reduce development risks and successfully navigate complex approval pathways with high quality, well documented bioanalytical results.
Roots Analysis has conducted an exhaustive study on Bioanalytical Testing Market featuring the current market landscape and future opportunity for the companies engaged in healthcare, over a span of next 10 years.
Top Six Leading Bioanalytical Testing CROs
1. BioAgilytix Labs
2. Catalent
3. Clean Cells
4. Charles River Laboratories
5. Eurofins
6. SGS
The figure below highlights the top six bioanalytical testing CROs:
Interested in exploring all ~120 players offering bioanalytical testing related services, along with their recent initiatives?
Discover Below the Details of 6 leading Bioanalytical Testing CROs
Let us dive deep into the details of the six leading bioanalytical testing CROs. It is essential to note that the selection of top players can differ substantially according to the defined criteria.
1.BioAgilytix Labs
Company Overview
BioAgilytix Labs claims to be a leading global bioanalytical laboratory committed to guiding clients through the scientific and regulatory complexities of bioanalysis for cutting-edge therapies. Notably, the company has all the required capabilities to manage bioanalytical projects across all phases of drug development. The firm primarily focuses on innovations offering end-to-end bioanalytical testing services, such as assay development, biomarker analysis, and pharmacokinetic assessments. Through its industry-leading expertise and customized solutions, the company supports even the most complex bioanalytical requirements, ultimately advancing the development of new therapies to improve patients’ lives.
List of Parameter Including Type of Testing, Type of Modality, Type of Workflow, Type of Technology and End Users
The section provides information on various parameters like type of testing offered by BioAgilytix Labs, along with details on the type of modality, type of workflow, type of technology and end users dedicated to bioanalytical testing.
- Type of Testing Offered: ADME, Pharmacokinetics, Pharmacodynamics, Bioavailability, Bioequivalence, Biomarker Testing, Cell-based Assay, Virology Testing
- Type of Modality: Monoclonal Antibodies, Cell Therapies, Gene Therapies, Biosimilars, Fusion Proteins, Peptides, Vaccines, Small Molecules, Other Biologics
- Type of Workflow: Sample Collection and Preparation, Method Development and Validation, Sample Analysis
- Type of Technology: Traditional Methods, Rapid Microbiological Methods, Cell-Based Assay
- End Users: Pharmaceutical and Biotechnology Companies, CROs / CDMOs
Recent Developments
In May 2025, the company announced the expansion of its global CMC analytical testing capabilities with the completion of a 76,000 sq.ft. campus in North Carolina. This facility includes a 26,000 sq.ft. GMP-compliant laboratory designed to enhance testing capacity, scalability, and regulatory preparedness.
To know more about the recent initiatives of BioAgilytix Labs and other bioanalytical testing CROs, access full report.
2.Catalent
Company Overview
Catalent claims to be a leading global provider of advanced delivery technologies, development solutions, and manufacturing services for drugs, biologics, and cell and gene therapies. Having extensive expertise across the pharmaceutical domain, the company supports its partners from preclinical development to commercial supply. Moreover, Catalent’s integrated network of facilities delivers end-to-end capabilities, including formulation, dosage form optimization, and large-scale manufacturing. Further, Catalent offers specialized services for protein, viral vector, and mRNA-based products. Its bioanalytical testing capabilities encompass method development, validation, and sample analysis for both small and large molecules, ensuring regulatory compliance and robust data integrity throughout all study phases. Notably, in 2024 the company was acquired by Novo Nordisk.
List of Parameter Including Type of Testing, Type of Modality, Type of Workflow, Type of Technology and End Users
The section provides information on various parameters like type of testing offered by Catalent, along with details on the type of modality, type of workflow, type of technology and end users dedicated to bioanalytical testing.
- Type of Testing Offered: Pharmacokinetics, Pharmacodynamics, Cell-based Assay, Bioassay
- Type of Modality: Monoclonal Antibodies, Cell Therapies, Gene Therapies, Fusion Proteins, mRNA, Vaccines, Other Biologics
- Type of Workflow: Method Development and Validation
- Type of Technology: Cell-Based Assay
Recent Developments
In February 2025, Catalent announced the appointment of Susan Mahoney, former Pfizer executive and renowned leader in vaccines and oncology, to its Board of Directors. This strategic addition brings deep expertise in global drug development, regulatory affairs, and innovative therapies, strengthening Catalent's governance as it advances analytical, mRNA manufacturing, cell/gene therapies, and precision medicine solutions amid rapid industry growth.
To know more about the recent initiatives of Catalent and other bioanalytical testing CROs, access full report.
3.Clean Cells
Company Overview
Clean Cells is a GMP-licensed CMO / CRO that provides research and development, production, and quality control testing services to the biopharmaceutical industry. As per the company’s website, they have a dual-site facility in Western France that features an innovative platform for process development, along with BSL2 and BSL3 GMP manufacturing labs and analytical labs designed to develop custom assays and conduct GMP testing. It is worth highlighting that the company leverages the extensive expertise of its sister company Naobios, a CMO with substantial experience in the development and production of virus-based products.
List of Parameter Including Type of Testing, Type of Modality, Type of Workflow, Type of Technology and End Users
The section provides information on various parameters like type of testing offered by Clean Cells, along with details on the type of modality, type of workflow, type of technology and end users dedicated to bioanalytical testing.
- Type of Testing Offered: Cell-based Assay, Virology Testing
- Type of Modality: Cell Therapies, Vectors
- Type of Workflow: Method Development and Validation
- Type of Technology: Rapid Microbiological Methods, Next Generation Sequencing
- End Users: Pharmaceutical and Biotechnology Companies
Recent Developments
In April 2025, Clean cells announced the expansion of its identity testing services for clean cells, integrating advanced next-generation sequencing (NGS) technology into both cGMP-compliant and non-GMP grade identity tests. This enhancement delivers precise genetic verification, faster turnaround times, and superior sensitivity for cell line authentication, supporting biopharma R&D, manufacturing scalability, and regulatory compliance in cell therapy development.
To know more about the recent initiatives of Clean Cells and other bioanalytical testing CROs, access full report.
4.Charles River Laboratories
Company Overview
Charles River Laboratories is a global CRO that offers a comprehensive suite of preclinical, clinical, and bioanalytical testing services to the pharmaceutical and biotechnology industries. With a network of over 100 facilities across more than 20 countries, the company employs thousands of professionals who support drug, vaccine, and medical device development. Further, Charles River is recognized for its expertise in oncology, infectious diseases, rare genetic disorders, and advanced bioanalytical testing capabilities, including toxicology studies, safety assessments, and microbial testing used in regulatory submissions. The company collaborates with multiple biopharma partners to facilitate innovative therapies, continually expanding its services through strategic acquisitions and global operations.
List of Parameter Including Type of Testing, Type of Modality, Type of Workflow, Type of Technology and End Users
The section provides information on various parameters like type of testing offered by Charles River Laboratories, along with details on the type of modality, type of workflow, type of technology and end users dedicated to bioanalytical testing.
- Type of Testing Offered: ADME, Pharmacokinetics, Pharmacodynamics, Biomarker Testing, Cell-based Assay, Virology Testing, Bioassay
- Type of Modality: Monoclonal Antibodies, Cell Therapies, Gene Therapies, Vaccines, Vectors
- Type of Workflow: Method Development and Validation
- Type of Technology: Traditional Methods, Rapid Microbiological Methods, Cell-Based Assay, Chromatographic & Electrophoretic Techniques, Next Generation Sequencing
- End Users: Pharmaceutical and Biotechnology Companies, CROs / CDMOs
Recent Developments
In September 2025, Charles River Laboratories announced the addition of new space and capabilities in its Erkrath Biologics testing facility. This includes the inclusion of LC and MS technologies for conducting the residual host cell protein quantification and characterization.
To know more about the recent initiatives of Charles River Laboratories and other bioanalytical testing CROs, access full report.
5.Eurofins
Company Overview
Eurofins is a leading global life sciences organization recognized for its extensive expertise in bioanalytical testing. With a network of over 1,000 laboratories across more than 60 countries, the company delivers comprehensive analytical services that support pharmaceutical, biopharmaceutical, and biotechnology sectors. Eurofins’ bioanalytical testing capabilities encompass a broad range of validated methods for the quantitative and qualitative analysis of small molecules, biologics, and biomarkers. Leveraging advanced technologies and a strong regulatory framework, the company ensures full compliance with global guidelines, helping clients mitigate analytical and compliance risks throughout the drug development lifecycle.
List of Parameter Including Type of Testing, Type of Modality, Type of Workflow, Type of Technology and End Users
The section provides information on various parameters like type of testing offered by Eurofins, along with details on the type of modality, type of workflow, type of technology and end users dedicated to bioanalytical testing.
- Type of Testing Offered: ADME, Pharmacokinetics, Bioavailability, Biomarker Testing, Cell-based Assay, Virology Testing, Bioassay
- Type of Modality: Monoclonal Antibodies, Cell Therapies, Gene Therapies, Peptides, Vaccines, mRNA
- Type of Workflow: Sample Collection and Preparation, Sample Analysis
- Type of Technology: Traditional Methods, Rapid Microbiological Methods, Cell-Based Assay
- End Users: Pharmaceutical and Biotechnology Companies
Recent Developments
In March 2025, Eurofins Scientific announced the appointment of Gavin Hill as a new independent non-executive director to its board. With extensive expertise in life sciences and strategic leadership from prior roles in biotech and diagnostics firms, Hill will bolster governance and innovation oversight. This move strengthens Eurofins' position in bioanalytical testing and global market expansion amid growing demand for advanced molecular diagnostics.
To know more about the recent initiatives of Eurofins and other Bioanalytical testing manufacturers, access full report.
6.SGS
Company Overview
SGS is a global provider of bioanalytical testing solutions, supporting pharmaceutical and biopharmaceutical companies across all stages of drug development. Its bioanalytical testing services combine scientific expertise, advanced instrumentation, and regulatory compliance to deliver accurate and reproducible data. SGS delivers comprehensive support for both small and large molecules, including biologics, biosimilars, gene therapies, and vaccines. With its GLP- and GCLP-compliant laboratories strategically located worldwide, the company ensures high-quality results that meet international regulatory standards.
List of Parameter Including Type of Testing, Type of Modality, Type of Workflow, Type of Technology and End Users
The section provides information on various parameters like type of testing offered by SGS, along with details on the type of modality, type of workflow, type of technology and end users dedicated to bioanalytical testing.
- Type of Testing Offered: ADME, Pharmacokinetics, Pharmacodynamics, Biomarker Testing, Cell-based Assay, Virology Testing, Bioassay
- Type of Modality: Monoclonal Antibodies, Cell Therapies, Gene Therapies, Biosimilars, Peptides, mRNA, Vectors, Small Molecules, Other Biologics
- Type of Workflow: Method Development and Validation
- Type of Technology: Traditional Methods, Rapid Microbiological Methods, Cell-Based Assay
- End Users: Pharmaceutical and Biotechnology Companies, CROs / CDMOs
Recent Developments
In October 2025, the company announced it will continue to position its bioanalytical labs as a single, integrated network for large-molecule and advanced-therapy bioanalysis, enabling sponsors to run global clinical trials with consistent methods and regulatory alignment.
To know more about the recent initiatives of SGS and other bioanalytical testing CROs, access full report.
Bioanalytical Testing Services Market Trends in North America
North America is shifting toward integrated, multi-modality bioanalytical testing that handle small molecules, monoclonal antibodies, oligonucleotides, and cell / gene therapies in a single workflow. Demand is driven by complex modalities requiring combined LC-MS / MS, ligand-binding, qPCR / ddPCR, and cell-based assays, especially for immunogenicity and biomarker readouts. Leading players include Altasciences, ARL Biopharma, Biomere, Frontage Lab, IQVIA Laboratories, KCAS Bio, PPD (Acquired by Thermo Fisher), Resolian, Royalmount Pharma and Syneos Health.
The figure below highlights the leading bioanalytical testing CROs based in North America:
What About Other Bioanalytical Testing CROs Around the World?
The above article features the leading bioanalytical testing CROs selected from a pool of around 120 companies that we have compiled. If you're interested, you can download the Sample Report on this topic by Roots Analysis. For personalized assistance in identifying the most relevant solutions based on your specific criteria, please don't hesitate to reach out to us at sales@rootsanalysis.com.
Sources:
2. https://www.catalent.com/catalent-news/catalent-announces-new-board-appointments/
4. https://www.criver.com/insights/meeting-the-moment-in-biologics-testing